Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
BSX:ETR
Boston Scientific Corp
€48,62
+0,38%
(+0,18) 1D
30 Apr., 17:35:47 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BSX...
Open
€48,86
High
€49,14
Low
€48,34
Mkt. cap
83,97 mjd
Avg. vol.
2,10 k
Volume
415,00
52-wk high
€95,20
52-wk low
€48,34
No. of employees
59 k
News stories
From sources across the web
Profile
Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. The company is known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. The company acquired Cameron Health in June 2012 and began to offer a minimally invasive implantable cardioverter-defibrillator called the EMBLEM subcutaneous implantable defibrillator. Over the last 20 years, Boston Scientific has had some high-profile patent infringement cases. It has made extensive payouts, including $1.725 billion to Johnson & Johnson, $85 million to Nevro and $42 million to TissueGen. BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware. Wikipedia
About Boston Scientific Corp
CEOMichael F. Mahoney
Employees59 k
Founded29 Jun. 1979
HeadquartersMarlborough, Massachusetts, Verenigde State van Amerika
SectorMedical device
Websitebostonscientific.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun. 2025
Sep. 2025
Des. 2025
Mrt. 2026
Revenue
5,06 mjd
5,06 mjd
5,29 mjd
5,20 mjd
Cost of goods sold
1,65 mjd
1,54 mjd
1,61 mjd
1,55 mjd
Cost of revenue
1,65 mjd
1,54 mjd
1,61 mjd
1,55 mjd
Research and development expenses
526,00 m
514,00 m
569,00 m
516,00 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,72 mjd
1,74 mjd
1,83 mjd
1,78 mjd
Operating expense
2,47 mjd
2,48 mjd
2,63 mjd
2,53 mjd
Total operating expenses
4,12 mjd
4,02 mjd
4,24 mjd
4,08 mjd
Operating income
943,00 m
1,05 mjd
1,04 mjd
1,12 mjd
Other non operating income
440,00 m
-16,00 m
28,00 m
-19,00 m
EBT including unusual items
941,00 m
938,00 m
700,00 m
1,16 mjd
EBT excluding unusual items
1,29 mjd
935,00 m
1,01 mjd
1,01 mjd
Income tax expense
146,00 m
183,00 m
30,00 m
-176,00 m
Effective tax rate
15,52%
19,51%
4,29%
-15,13%
Other operating expenses
-
-
-
-
Net income
797,00 m
755,00 m
672,00 m
1,34 mjd
Net profit margin
15,75%
14,91%
12,71%
25,77%
Earnings per share
0,75
0,75
0,80
0,80
Interest and investment income
-
-
29,00 m
-
Interest expense
-90,00 m
-87,00 m
-90,00 m
-90,00 m
Net interest expenses
-90,00 m
-87,00 m
-61,00 m
-90,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
1,28 mjd
1,39 mjd
1,41 mjd
1,46 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer